Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy.

E O KrepsS J EppsA ConsejoAndrew D DickC M GulyA V Ramanan

Published in: Eye (London, England) (2023)

This study supports the efficacy and safety of infliximab in adalimumab-refractory patients with paediatric non-infectious uveitis.

Keyphrases